STOCK TITAN

American Well Corp Stock Price, News & Analysis

AMWL NYSE

Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.

American Well Corp (AMWL) is a leading telehealth platform enabling digital care solutions across healthcare ecosystems. This page serves as the definitive source for verified news and official announcements from the company, providing stakeholders with timely insights into strategic developments.

Access comprehensive updates including earnings reports, technology innovations, partnership announcements, and regulatory milestones. Investors and industry observers can track AMWL's progress in advancing hybrid care models and expanding its digital health infrastructure.

All content is curated to ensure relevance to AMWL's operations in virtual care delivery, platform enhancements, and collaborations with healthcare providers. Bookmark this page for efficient monitoring of the company's evolving role in shaping accessible, technology-driven healthcare solutions.

Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the issuance of Restricted Stock Units (RSUs) to four new employees as employment inducements. The grants, approved by the company's Compensation Committee, total 16,737 shares of Class A common stock. The vesting schedule includes 25% of RSUs vesting on the first anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over the following three years, contingent on continued employment. These grants were made under Amwell's Inducement Plan and comply with NYSE's Listed Company Manual Rule 303A.08.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.65%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL), a leading SaaS-based healthcare platform provider, has announced its participation in the TD Cowen 24th Annual Health Care conference in Boston. Dr. Ido Schoenberg, Amwell's chairman and CEO, will engage in a fireside chat on March 4 at 9:10 a.m. ET, along with one-on-one meetings during the conference. Investors can access the audio webcast of the fireside chat through the company's investor relations website at investors.amwell.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.44%
Tags
conferences
-
Rhea-AI Summary

Amwell (NYSE: AMWL), a provider of SaaS-based technology-enabled healthcare platform, has announced its financial results for the fourth quarter and full year 2024. The company will discuss these results during a conference call scheduled for February 12, 2025, at 5 p.m. ET. Investors can access the earnings report through Amwell's investor relations website, and a live audio webcast of the conference call will be available. A replay of the call will be accessible via webcast on the investor relations website after the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.02%
Tags
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced it will release its fourth quarter and full year 2024 operating results after market close on Wednesday, February 12, 2025. The company will host a conference call and webcast at 5:00 PM ET on the same day, where management will discuss the financial results and provide business updates. The earnings report and webcast will be accessible through the Investors section of Amwell's website, with a replay available for approximately 90 days at investors.amwell.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.9%
Tags
conferences earnings
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the addition of Vida Health to its clinical programs portfolio, expanding its virtual cardiometabolic care offerings. The new program, Amwell Cardiometabolic Care Powered by Vida, will provide obesity and diabetes care services, including GLP-1s and anti-obesity medications, through Amwell's platform to health plans and employers.

The program will offer personalized care considering social factors like food security, financial barriers, and cultural norms. Vida's services will integrate with Amwell's existing virtual primary care, urgent care, and behavioral health programs. The partnership aims to address the significant healthcare challenge of obesity, which affects over 40% of American adults and, combined with diabetes, costs the U.S. healthcare system more than $500 billion annually.

The collaboration focuses on delivering value-based, outcomes-driven care through lifestyle interventions and Medical Nutrition Therapy, providing members with a unified entry point for clinical and behavioral health support.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.64%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the sale of its Amwell Psychiatric Care (APC) business to Avel eCare for approximately $21M in cash, plus an additional earn-out payment. The divestment includes APC technology, personnel, and the Asana psychiatric clinical network.

The strategic move aims to sharpen Amwell's focus on key growth areas and its unified digital care platform. Through Amwell Medical Group (AMG), the company will continue providing behavioral health services, including AMG Therapy Services and SilverCloud digital behavioral health.

Amwell has reiterated its 2024 guidance, projecting:

  • Revenue between $247-252 million
  • Adjusted EBITDA between ($137)-($142) million
  • AMG visits between 1.4-1.5 million

The company maintains its goal of achieving positive cash flow in 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced that CFO Mark Hirschhorn will expand his role to include Chief Operating Officer responsibilities, effective January 1, 2025. While maintaining his CFO duties, Hirschhorn will oversee operational and growth strategies, including clinical, sales, and marketing teams. The company aims to streamline its portfolio and pursue profitable growth, targeting cash flow positivity by 2026.

As part of the organizational restructuring, two executives will depart at year-end: Chief Commercial and Growth Officer Kathy Weiler and current COO Kurt Knight. Weiler contributed to cost initiatives and growth organization transformation, while Knight's 14-year tenure included key roles in strategy, M&A, IPO, COVID-19 operations scaling, and managing Amwell Medical Group.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) announced equity compensation grants to new employees under its Inducement Plan. The company granted 254,227 restricted stock units (RSUs) to Mark Hirschhorn, its new CFO, with 25% vesting immediately and the remaining 75% vesting quarterly over three years. Hirschhorn is also eligible for an additional $5 million grant subject to EBITDA targets and company valuation goals, vesting annually over four years. Additionally, 5,084 RSUs were granted to two other new employees, with 25% vesting after one year and the remaining 75% vesting quarterly over three years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL), a leading provider of healthcare software as a service, reported its third quarter 2024 financial results for the period ending Sept. 30, 2024. The company will host a conference call today at 5 p.m. ET to discuss these results. The call can be accessed via a live audio webcast on Amwell's investor relations website or by dialing 1-888-510-2008 for U.S. participants and 1-646-960-0306 for international participants, using conference ID number 7830032. A replay will be available shortly afterward on the same website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.08%
Tags
Rhea-AI Summary

Amwell (NYSE: AMWL), a digital care leader, has announced its participation in four upcoming investor conferences in November and December 2024. Chairman and CEO Ido Schoenberg and CFO Mark Hirschhorn will engage in fireside chats and one-on-one meetings at these events.

The schedule includes the UBS Global Healthcare Conference in Palos Verdes on Nov. 12, the Needham Consumer Tech Conference on Nov. 20, the BTIG Virtual Health Forum on Nov. 25, and the Piper Sandler Healthcare Conference in New York on Dec. 4. Audio webcasts of the fireside chats will be accessible at investors.amwell.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.53%
Tags
conferences

FAQ

What is the current stock price of American Well (AMWL)?

The current stock price of American Well (AMWL) is $5.6 as of October 21, 2025.

What is the market cap of American Well (AMWL)?

The market cap of American Well (AMWL) is approximately 90.6M.
American Well Corp

NYSE:AMWL

AMWL Rankings

AMWL Stock Data

90.61M
13.17M
5.61%
44.02%
1.05%
Health Information Services
Services-business Services, Nec
Link
United States
Boston